SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

SHA SHAPE Australia Corporation Limited

Industrials · Engineering & Construction · website · 890 employees
$8.12
52wk 4.88 – 8.15
Overall
75.4
Value
58.7
Growth
92.5
Health
71.5
Quality
57.8
Momentum
99.8
Dividend
72.7
Price
About SHAPE Australia Corporation Limited

SHAPE Australia Corporation Limited, together with its subsidiaries, engages in the construction, fitout, and refurbishment of commercial properties in Australia. The company also offers new builds, facade remediation, modular construction, design and build, and aftercare and facilities maintenance services. It serves commercial office, accommodation, health, education, hotels, government, defense, transport, aged care, retail, community, mining, agriculture, and entertainment and recreation sectors. The company was founded in 1989 and is headquartered in Sydney, Australia.

Price analytics

Returns

1 day 8.3%
1 week 10.9%
1 month 8.1%
3 months 25.7%
6 months 19.1%
1 year 64.0%
3 years 412.3%

Risk

Volatility (1y ann.) 43.0%
Beta vs ASX 200 0.91
Sharpe (1y) 1.27
VaR 95% (1-day) -3.6%
Max drawdown (1y) -23.2%
Off 1-year high 0.0%

Technicals

RSI(14) 77 OB
vs 50DMA 15.4%
vs 200DMA 20.2%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 58.7
Trailing P/E
62
Forward P/E
64
PEG ratio
—
EV / EBITDA
60
Price / Book
0
Price / Sales
100
Growth 92.5
Revenue growth (1y)
100
Revenue CAGR (3y)
72
EPS growth (1y)
100
EPS CAGR (3y)
100
Financial Health 71.5
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
18
Debt / Equity
63
Quality (Profitability & Cash Flow) 57.8
Return on equity
100
Return on assets
92
Operating margin
16
Net margin
17
Cash conversion (OCF / net income)
—
Dividend / Income 72.7
Dividend yield (%)
80
Payout ratio
60
FCF dividend cover
79
Momentum 99.8
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
100
Position in 52-week range
99

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$690.04M
P/E (trailing)
21.95
P/E (forward)
17.59
EPS (trailing)
0.37
Dividend yield
4.4%
Payout ratio
71.9%
Beta
0.31
EV / EBITDA
11.33
Price / Book
15.23
ROE
78.5%
Operating margin
4.0%
Net margin
2.6%
Total cash
$136.23M
Total debt
$38.10M
Current ratio
1.11
Debt / Equity
0.86
Free cash flow
$38.78M
Avg volume
141,834
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$1.23B
  • Gross profit$1.23B
  • Operating income$39.91M
  • Net income$31.73M
  • Diluted EPS—
  • Free cash flow$47.48M
  • Net debt-$65.84M
Sector peers (Industrials)
TickerMkt cap P/EScore
TCL $40.91B 109.2 29.1
BXB $25.26B 19.0 54.6
QAN $13.30B 10.5 48.5
AIA $11.49B 42.3 39.0
IFT $11.18B 50.9 36.5
ALQ $10.64B 33.3 52.8
REH $10.30B 33.5 49.3
QUB $9.12B 42.6 37.9